Alkermes plc

Major-Pharmaceuticals

ALKS


Connaught House
Dublin , 4

Executive/
Director

Price

  • Last Close
  • $ 29.04
    $ +0.28 0.97 %
    Jan 3, 2025
  • 52-Week High/Low
  • $32.56 - $23.19
  • YTD
  • 1%

  • Trading Volume
  • 39,919
  • Market Cap Full
  • $ 4.8B
  • Shares Outstanding
  • 166.9M
    Oct 20, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -56.9% 5.3% 5.9% 23.7% -5% -5.4% 14.9% 7.9% -3.1% 1%
Q2 26.4% -0.9% -9% -38% 4% 29.9% 11% 11% -10.9% -
Q3 8.8% -12.3% 1.3% -16.4% 8% 25.8% -25% -10.5% 3.9% -
Q4 18.2% 5.8% -31.2% 6% 20.7% -24.2% 17% -1.2% -8.1% -
J F M A M J J A S O N D
2025 1% - - - - - - - - - - -
2024 -2.5% 9.8% -9.4% -10.5% -2.8% 3.8% 12.5% 3.9% - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    36%-30%-2%-46%-31%-2%17%12%6%4%1%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.32 0.31 -0.4 -0.62 -0.24 -0.14 -0.22 -0.25
Q2 0.18 0.13 -0.21 -0.27 -0.19 0.01 -0.18 1.38
Q3 0.25 0.09 -0.22 -0.34 - -0.18 -0.39 0.28
Q4 0.04 0.20 -0.07 -0.02 -0.27 0.01 -0.18 -
A 0.8 0.7 -0.9 -1.3 -0.7 -0.3 -1 1.41

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 156 157.8 159.2 162 164.4
Jun 155 156.9 158.7 160.5 163.4 166.1
Sep 155.3 157.1 159 161.3 164.3 166.6
Dec 155.4 157.5 159.1 161.7 164.3 166.9

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 1.2 1.3 1.4 1.8 2
Fixed Asset Turnover 2.4 2 2.5 2.4 2.3
Total Asset Turnover 0.6 0.6 0.5 0.7 0.6
Leverage
Debt Ratio 0.3 0.3 0.2 0.3 0.3
Debt – Equity Ratio 0.3 0.3 0.3 0.3 0.2
Interest Coverage -8.9 -1.5 112 -8 -2.5
Equity multiplier 0.5 0.5 0.4 0.5 0.4